Thank you, Mr. Chair.
Thank you for the opportunity to speak to the committee.
I am here on behalf of Genome Canada and I am joined today by Dr. Cindy Bell, who has been with Genome Canada since we were founded 20 years ago. It played an important science leadership role during the SARS outbreak in 2003 and is doing so again today.
We're very pleased today to join colleagues from the University of Toronto, the Canadian Society for Molecular Biosciences, and the Vaccine and Infectious Disease Organization based at the University of Saskatchewan, to share insights from Canada's bioscience community and to engage in dialogue with committee members.
I want to pay tribute to the front-line workers in hospitals, in grocery stores, in pharmacies, at truck stops and at take-out counters.
I'm also thinking of the millions of Canadians who make sacrifices every day to help fight COVID-19.